Effect of Cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] Study)

American Journal of Cardiology

Volumn 111, Issue 12, 2013, Pages 1681-1687

  Patel, Dhavalkumar ^a,b   Ahmad, Soha ^a   Silverman, Angela ^c   Lindsay, Joseph ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RECORD REVIEW; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CANADA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYSTATIN C; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

EID: 84878884399     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.019     Document Type: Article

References (22)

1. L.A. Inker, C.H. Schmid, H. Tighiouart, J.H. Eckfeldt, H.I. Feldman, T. Greene, J.W. Kusek, J. Manzi, F. Van Lente, Y.L. Zhang, J. Coresh, A.S. Levey CKD-EPI Investigators Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 2012 20 29
2. B.A. Perkins, R.G. Nelson, B.E. Ostrander, K.L. Blouch, A.S. Krolewski, B.D. Myers, and J.H. Warram Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study J Am Soc Nephrol 16 2005 1404 1412
3. M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, A.B. Newman, D.S. Siscovick, and C. Stehman-Breen Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
4. J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 173 179
5. M.J. Sarnak, R. Katz, C.O. Stehman-Breen, L.F. Fried, N.S. Jenny, B.M. Psaty, A.B. Newman, D. Siscovick, and M.G. Shlipak Cystatin C concentration as a risk factor for heart failure in older adults Ann Intern Med 142 2005 497 505
6. L.F. Fried, R. Katz, M.J. Sarnak, M.G. Shlipak, P.H. Chaves, N.S. Jenny, C. Stehman-Breen, D. Gillen, A.J. Bleyer, C. Hirsch, D. Siscovick, and A.B. Newman Kidney function as a predictor of noncardiovascular mortality J Am Soc Nephrol 16 2005 3728 3735
7. M.G. Shlipak, C.L. Wassel Fyr, G.M. Chertow, T.B. Harris, S.B. Kritchevsky, F.A. Tylavsky, S. Satterfield, S.R. Cummings, A.B. Newman, and L.F. Fried Cystatin C and mortality risk in the elderly: the health, aging, and body composition study J Am Soc Nephrol 17 2006 254 261
8. W.F. Owen, and E.G. Lowrie C-reactive protein as an outcome predictor for maintenance hemodialysis patients Kidney Int 54 1998 627 636
9. N.D. Vaziri, E.C. Gonzales, J. Wang, and S. Said Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis Am J Kidney Dis 23 1994 828 835
10. F. Stam, C. van Guldener, A. Becker, J.M. Dekker, R.J. Heine, L.M. Bouter, and C.D. Stehouwer Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study J Am Soc Nephrol 17 2006 537 545
11. P. Muntner, J. He, B.C. Astor, A.R. Folsom, and J. Coresh Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study J Am Soc Nephrol 16 2005 529 538
12. R.N. Foley, C. Wang, and A.J. Collins Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study Mayo Clin Proc 80 2005 1270 1277
13. J. Hsia, E.L. Alderman, J.I. Verter, W.J. Rogers, P. Thompson, B.V. Howard, F.R. Cobb, P. Ouyang, J.C. Tardif, L. Higginson, V. Bittner, I. Barofsky, M. Steffes, D.J. Gordon, M. Proschan, N. Younes, and D. Waters Women's angiographic vitamin and estrogen trial: design and methods Control Clin Trials 23 2002 708 727
14. D.D. Waters, E.L. Alderman, J. Hsia, B.V. Howard, F.R. Cobb, W.J. Rogers, P. Ouyang, P. Thompson, J.C. Tardif, L. Higginson, V. Bittner, M. Steffes, D.J. Gordon, M. Proschan, N. Younes, and J.I. Verter Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial JAMA 288 2002 2432 2440
15. A.S. Go, G.M. Chertow, D. Fan, C.E. McCullock, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
16. M. van der Velde, K. Matsushita, J. Coresh, B.C. Astor, M. Woodward, A. Levey, P. de Jong, R.T. Gansevoort Chronic Kidney Disease Prognosis Consortium Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 2011 1341 1352
17. B.F. Culleton, M.G. Larson, P.W.F. Wilson, J.C. Evans, P.S. Parfrey, and D. Levy Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 1999 2214 2219
18. N. Taglieri, W. Koenig, and J.C. Kaski Cystatin C and cardiovascular risk Clin Chem 55 2009 1932 1943
19. F. Gradaus, K. Ivens, A.J. Peters, P. Heering, F.C. Schoebel, B. Grabensee, and B.E. Strauer Angiographic progression of coronary artery disease in patients with end-stage renal disease Nephrol Dial Transplant 16 2001 1198 1202
20. 2: a meta-analysis of intravascular ultrasound studies Am J Cardiol 99 2007 813 816
21. C. Rigatto, A. Levin, A.A. House, B. Barrett, E. Carlisle, and A. Fine Atheroma progression in chronic kidney disease Clin J Am Soc Nephrol 4 2009 291 298
22. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874